Yanqiong Zhou
Shantou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A comprehensive assessment of cholinesterase inhibitors for the treatment of Alzheimer's disease based on drug selection recommendations for Chinese medical institutions.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: August 08, 2026
Adverse event reporting patterns of rituximab and obinutuzumab in B-cell non-Hodgkin lymphoma: a FAERS pharmacovigilance study.
Journal: Frontiers in immunology
Published: April 14, 2026
Molecular, biofilm and motility characterization of Acinetobacter baumannii isolated from a neonatal intensive care unit at a children's hospital in South China.
Journal: Frontiers in cellular and infection microbiology
Published: September 14, 2025
Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database.
Journal: Frontiers in pharmacology
Published: September 06, 2025
Efficacy and Safety of Telitacicept in Systemic Lupus Erythematosus.
Journal: Current pharmaceutical design
Published: June 30, 2025
Rapid health technology assessment of six non-ergot dopamine-receptor agonists for the treatment of early Parkinson's disease.
Journal: Frontiers in pharmacology
Published: June 18, 2025
Global research trends in palliative care for breast cancer from 2012 to 2022: A scientometric analysis.
Journal: Frontiers in oncology
Published: November 21, 2022
Corrigendum: Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis.
Journal: Frontiers in molecular biosciences
Published: March 21, 2022
Sevoflurane Alleviates Myocardial Ischemia Reperfusion Injury by Inhibiting P2X7-NLRP3 Mediated Pyroptosis.
Journal: Frontiers in molecular biosciences
Published: August 31, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026